MBVX - .6402 Pre-market now at .69/.7195 MabVax Says New Study Results Enable Manufacturing of Two Radionuclide Products for Phase 1 Development http://stockcharts.com/c-sc/sc?s=MBVX&p=D&b=5&g=0&i=t51082922583&r=1510580668789 http://stockcharts.com/c-sc/sc?s=MBVX&p=W&b=5&g=0&i=t78513523046&r=1510580690177